In the heart of India's diverse landscape, a silent but serious health threat looms large: sickle cell anemia (SCA). Across tribal communities and urban centers alike, its impact indicates the urgent need of 360-degree strategies to address it.
India accounts for 14.5 percent of newborns with sickle cell disease (SCD), estimated to be over 42,000 annually. The phenotype of SCD in India was considered mild due to factors like higher fetal hemoglobin levels or co-inheritance of alpha thalassemia. However, recent studies highlight the severity of the disease, especially among tribal populations. Before reaching the age of two, 20 percent of tribal children with SCD die, and 30 percent do not survive to adulthood.
SCD is caused by either homozygous inheritance of the hemoglobin S mutation (HBSS) or compound heterozygous inheritance of the hemoglobin S mutation with another ẞ-globin chain abnormality. India has one of the highest hemoglobin S allele frequencies globally, and the third-highest birth rate for babies born with HbSS. The beta-sickle globin mutation (BS) is particularly common among aboriginal tribal populations (Adivasis) and historically disadvantaged groups known as scheduled castes. An estimated 1 in 86 births in these populations results in sickle cell anemia.
Stating that the situation is alarming along the Narmada River belt, Mahanadi River belt, and the jungles of Odisha, Dr Dinesh Pendharkar, Director - Oncology, Cell and Gene Therapy and Bone Marrow Transplantation, Sarvodaya Hospital, Sector 8, Faridabad, informs, "There are approximately 100 districts with a high prevalence. The average number of patients in these ranges varied between 1,000 and 2,000.The total number in the country is approximately three-lakh. In Africa most sickle cell anemia patients die before five years of age. Our child mortality data are not available."
Diese Geschichte stammt aus der July 2024-Ausgabe von Healthcare Radius.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der July 2024-Ausgabe von Healthcare Radius.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
KIMSHEALTH launches electrophysiology lab with 3D mapping
'ENSITE X' is the first of its kind in Kerala and the third in India enabling precise identification, mapping, and targeting the abnormal electrical activities in the heart.
Molbio boosts Goa's healthcare system with CSR initiatives
The company has donated four state-of-the-art Advanced Life Support (ALS) ambulances and two hearse vans for National Highway emergencies
USV introduces affordable heart failure medication
This cost-effective option addresses the rising cases of heart failure in India, offering lifesaving care to millions of patients who need it the most.
City Imaging & Clinical Labs to expand services to 50 hospitals
The company is currently associated with 10 hospitals, providing comprehensive lab management services, including 24/7 in-house phlebotomy and lab testing.
Oncare raises $1 million in seed funding, to set up 10 units
Oncare has raised $1 million in a seed funding round led by Huddle Ventures. It plans to deploy the raised capital to expand its operations to 10 new centers.
Nutrabay forays into Ayurvedic supplements market with Shilajit
Nutrabay's aims at gaining market share from the existing ayurveda supplements market with a distinctive product proposition and education about the benefits of Shilajit.
INDIA'S PREPAREDNESS ON HEALTHCARE-ASSOCIATED INFECTIONS: A GROWING FOCUS ON PATIENT SAFETY
The country's diverse healthcare landscape necessitates a flexible and multifaceted approach to infection control that can be adapted to various settings and resource levels.
TRANSFORMING CARDIAC SURGERY: HOW AI IS REVOLUTIONIZING PATIENT CARE AND OUTCOMES
Dr. Swarup Swaraj Pal shared his insights on the current state and future prospects of AI in cardiac procedures.
BEYOND THE LAB: THE CRITICAL ROLE OF LOGISTICS IN INDIA'S PHARMACEUTICAL INDUSTRY
As India continues to expand its role in the global pharmaceutical market, the importance of a robust, reliable, and innovative logistics infrastructure cannot be overstated.
LIFESTYLE DISEASES IN CHILDREN: A WAKE-UP CALL FOR A HEALTHIER GENERATION
In today's fast-paced world, children face an unexpected enemy: lifestyle diseases. Conditions like obesity, Type 2 diabetes, and hypertension are now affecting our youth. What's causing this shift, and how can we combat it?